Related Experiment Video
Updated: May 2, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer
Takao Kamai1, Toshihiko Tsujii, Kyoko Arai
1Department of Urology, Dokkyo University School of Medicine, Tochigi 321-0293, Japan. kamait@dokkyomed.ac.jp
Purpose:
The small GTP-binding protein Rho and its best-characterized downstream effector Rho-associated serine-threonine protein kinase, ROCK, participate in actin cytoskeleton organization, and are linked to pathogenesis and progression of several human tumors. We investigated the roles of Rho and ROCK in bladder cancer.
Experimental Design:
Using Western blotting, we quantitated Rho and ROCK protein expression in paired tumor and nontumor surgical samples from 107 consecutive Japanese patients with bladder cancer.
Results:
RhoA, RhoC, and ROCK were more abundant in tumors and metastatic lymph nodes than in nontumor bladder and uninvolved lymph nodes (P < 0.0001). Amounts of RhoA and RhoC protein, and ROCK protein expression correlated positively with one another (P < 0.0001). High RhoA, RhoC, and ROCK expression were related to poor tumor differentiation (P < 0.05, P < 0.01, and P < 0.01, respectively), muscle invasion (P < 0.001), and lymph node metastasis (P < 0.05). Kaplan-Meier plots linked high RhoA, RhoC, and ROCK protein expression to shortened disease-free and overall survival (P < 0.0001). By univariate analysis, high RhoA, RhoC, and ROCK protein expression predicted shortened disease-free and overall survival (P < 0.0001). By multivariate analysis, only RhoC was independently influenced in disease-free survival (P < 0.05), and RhoA and RhoC in overall survival (P < 0.001). In contrast, RhoB expression was inversely related to the grade and stage (P < 0.05), and its higher expression is associated with better overall survival (P < 0.05). In superficial tumors (Ta or T1; 63 patients), RhoA, RhoC, and ROCK were unrelated with recurrence-free survival. Overall survival in tumors invading muscle (T2 to T4; 44 patients) was significantly influenced by RhoA, RhoC, and ROCK in a Kaplan-Meier analysis (P < 0.0001, P < 0.0001, and P < 0.01, respectively). Whereas RhoA, RhoC, and ROCK independently predicted shortened overall survival in patients with invasive tumor by univariate analysis (P < 0.0001, P < 0.0001, and P < 0.01, respectively), only RhoC did so by multivariate analysis (P < 0.05).
Conclusion:
Rho/ROCK pathway apparently involved in occurrence and progression of bladder cancer may be valuable prognostic markers.
Insights
The Rho/ROCK pathway is involved in bladder cancer progression. High expression of RhoA, RhoC, and Rho-associated kinase (ROCK) correlates with poor prognosis, while RhoB indicates better survival, suggesting their potential as prognostic markers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The Rho GTP-binding protein and its effector Rho-associated kinase (ROCK) are implicated in the pathogenesis and progression of various human tumors.
- These proteins play a crucial role in organizing the actin cytoskeleton, a process vital for cell structure and motility.
Purpose of the Study:
- To investigate the specific roles of Rho and ROCK in the development and progression of bladder cancer.
- To evaluate the potential of Rho and ROCK as prognostic markers in bladder cancer patients.
Main Methods:
- Western blotting was employed to quantify the protein expression levels of Rho (RhoA, RhoB, RhoC) and ROCK.
- Protein expression was analyzed in paired surgical samples of bladder tumors and adjacent non-tumor tissues from 107 Japanese patients.
- Statistical analyses, including correlation, univariate, and multivariate analyses, were performed to assess the relationship between protein expression and clinical parameters.
Main Results:
- RhoA, RhoC, and ROCK were significantly upregulated in bladder tumors and metastatic lymph nodes compared to non-tumor tissues (P < 0.0001).
- Higher expression of RhoA, RhoC, and ROCK correlated with poor tumor differentiation, muscle invasion, and lymph node metastasis.
- Elevated RhoA, RhoC, and ROCK levels were associated with significantly shortened disease-free and overall survival (P < 0.0001).
- RhoB expression showed an inverse relationship with tumor grade and stage, and its higher expression was linked to better overall survival (P < 0.05).
- In muscle-invasive bladder cancers, RhoA, RhoC, and ROCK independently predicted shortened overall survival, with RhoC being a significant independent predictor in multivariate analysis.
Conclusions:
- The Rho/ROCK signaling pathway is demonstrably involved in the occurrence and progression of bladder cancer.
- RhoA, RhoC, and ROCK protein expression levels serve as valuable prognostic markers for bladder cancer patients.
- RhoB may represent a marker for a less aggressive form of bladder cancer.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

